René Eifler
12Patents
3h-index
13Co-inventors
53Inventor score
Filing activity: Oct 10, 2007 → Mar 8, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10898449B2 | Transdermal therapeutic system containing asenapine | Human Necessities | 5 | Active |
| US10980753B2 | Transdermal therapeutic system containing asenapine | Human Necessities | 4 | Active |
| US11033512B2 | Transdermal therapeutic system containing asenapine and silicone acrylic hybrid polymer | Human Necessities | 4 | Active |
| US11337932B2 | Transdermal therapeutic system containing asenapine and polysiloxane or polyisobutylene | Human Necessities | 3 | Active |
| US11648213B2 | Transdermal therapeutic system containing asenapine | Human Necessities | 2 | Active |
| US9833418B2 | Transdermal therapeutic system having controlled active substance flow comprising a basic reacting oxide | Emerging Cross-Sectional Technologies | 1 | Active |
| US10363228B2 | Transdermal administration of memantine | Human Necessities | 1 | Active |
| US11752109B2 | Controlling water release from a dimensionally stable aqueous composition | Human Necessities | 0 | Active |
| US9526736B2 | Transdermal therapeutic system comprising norelgestromin for contraception and hormone replacement | Human Necessities | 0 | Active |
| US12138353B2 | Transdermal therapeutic system containing asenapine | Human Necessities | 0 | Active |
| US12329862B2 | Transdermal therapeutic system containing asenapine | Human Necessities | 0 | Active |
| US9220691B2 | Transdermal therapeutic system comprising norelestromin for contraception and hormone replacement | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.